sion is restricted t o hematopoietic cells and tissues, but its function in the process of lineage commitment is unknown.
The present study was designed t o address the role of SCL in hematopoietic cell differentiation. SCL expression was determined in primary hematopoietic cells through the screening of cDNA samples obtained by reverse transcription-polymerase chain reaction (RT-PCR) from single cells at different stages of differentiation. SCL RNA expression was highest in bipotential and committed erythroid precursors and diminished with subsequent maturation t o proerythroblasts and normoblasts. In contrast, SCL mRNA was low to undetectable in precursors of granulocytes and monocytes and their maturing progeny. The same pattern of expression was RANSCRIPTION factors of the basic helix-loop-helix (bHLH) family have been shown to play a critical role in cell type specification and in developmental processes that include myogenesis, neurogenesis, and sex determination.' SCL'.' a bHLH transcription factor also known as Tal-l4 or TCL5,' was first identified because of its immediate proximity to the breakpoints of several chromosomal translocations associated with childhood acute T-cell lymphoblastic leukemias (ALL) that involve chromosome 1 : t( 1 ; 14), t( 1;7), t( 1;3), and del( l~).',',~-~ Rearrangements of the SCL locus involving chromosomal translocations or, more frequently, upstream deletions that are clustered within 2.5 kb of exon l b are found in 25% of childhood T-ALL'" and result in ectopic SCL expression.2,8.'," SCL has been shown to function as a transcription activator or repressor, but its target genes are unknown." The amino acid sequence is 94% iden-observed after erythroid or monocytic differentiation of a bipotent cell line, TF-1, in that SCL mRNA levels remained elevated during erythroid differentiation and were downregulated with monocytic differentiation. Accordingly, TF-1 was chosen as a model t o investigate the functional significance of this divergent pattern of SCL expression in the two lineages. Four independent clones stably transfected with an SCL expression vector exhibited enhanced spontaneous and delta-aminolevulinic acid-induced erythroid differentiation as measured by glycophorin expression and hemoglobinization, consistent with the view that SCL is a positive regulator of erythroid differentiation. Furthermore, constitutive SCL expression interfered with monocytic differentiation, as assessed by the generation of adherent cells and the expres- mast cell lines,'" and a variety of T cell lines," whereas monocytic and granulocytic cell lines were negative.
To further our understanding of the potential role of SCL in hematopoietic cell differentiation, we first sought to identify its pattern of expression in different hematopoietic progenitor classes, reasoning that a specific expression pattern within well-identified cell populations would be suggestive of functional importance. To circumvent problems associated with cellular heterogeneity, SCL expression was determined by examination of cDNA samples derived by reverse transcription-polymerase chain reaction (RT-PCR) from single precursor cells of known biologic This approach allows for a resolution not attained before with sorted pop~lations.''~~~ SCL RNA levels were high in pluripotential and early committed erythroid precursors and persisted through terminal maturation. In contrast, SCL RNA was lower in cells committed to the monocytic and granulocytic lineages and diminished further as they matured terminally.
Overexpression of SCL in MEL cells results in increased press granulocyte-macrophage colony-stimulating factor (GM-CSF). IL-3, and erythropoietin (Epo) receptors, c-Kit, and the surface antigens CD34 and CD333".'' (data herein). TF-I cells require GM-CSF for survival and expansion in culture""^" and have been shown to undergo 12-0-tetradecanoylphorbol-13-acetate (TPA)-induced monocytic differentiation or delta-aminolevulinic acid (ALA)-induced erythroid differentiation,'" allowing for an assessment of the role of SCL in these processes. AncrIysi.7 of sinale-cell cDNA. A 438-bp murine SCL probe corresponding to sequences immediately upstream of the polyadenylation signal' (Fig I ) was generated by PCR using CAT AAC CAC AGA GAG AAT CCC and ACA CTA TCA TCA CCA CAC TGG as S' and 3' primers. respectively. The identity of the amplified product was confirmed by restriction analysis as shown in Fig I. by thermal cycle sequencing with "S-deoxyadenosine triphosphate (dATP) and the Vent (exo-) DNA polymerase (Circumvent; New England Biolab. Beverly. MA), and by specific hybridization to the 4. I-kb SCL transcript on a Northern blot from differentiating MEL cells (data not shown). Southern blots of single-cell cDNA were exposed to a Phosphorhager screen (Molecular Dynamics. Sunnyvale. CA) and quantitated.
MATERIALS AND METHODS

Cells
Plnsrnids nnd transfection protocol. The SCL expression vector was pMSCL." in which the full-length human SCL coding region (HindllI-Rc~mH1 fragment) was placed under the influence of the metallothionein promoter. Stable transfectants were obtained through Lipofectin (Gibco)-mediated DNA transfer, as described previously." Briefly. exponentially growing cells were incubated for 6 hours with the Lipofectin-DNA complexes (S0 pg:20 pg) in serumfree medium. followed by an overnight rescue in FCS-containing medium. Cells were cloned through limiting dilution the following day. and selection with G41 8 ( I mglmL) was applied the next day. GM-CSF (5 nglmL) was present throughout the gene transfer proce- dure. All clones were expanded and maintained in G418-containing medium (S00 pglmL). The selective agent was removed for induction of cell differentiation and for establishing cumulative growth curves.
Northern blotting and qunnritntive RT-PCR. RNA was extracted from cells using the guanidium-acid phenol method.'' For Northern blotting, RNA samples were resolved through electrophoresis in 1 ?h agarose, in the presence of formaldehyde as described." Probes used were the I-kb X l m I fragment of the human genomic SCL clone.' the I .7-kb fragment of the human IL-I@ cDNA.'~ the 0.8-kb fragment of human a2-globin cDNA.'~ and the 1.2-kb f s t I-Toq I fragment of the human glyceraldehyde-3-phosphate dehydrogenase (GAPDH)
Inrlrtction of cell differentintion. Exponentially growing cells were induced with 2.5 m m o l k &ALA or 3 nmollL TPA. in the presence or in the absence of ZnClz (0. I mmol/L). These concentrations were optimal for erythroid and monocytic differentiation. respectively. On day 4 of erythroid induction. cells were harvested for analysis of glycophorin expression with the fluorescence-activated cell sorter (FACS). and on day S. for benzidine staining. Adherent cells were scored on day 2 of TPA induction. The cells were also or horseradish peroxidase-coupled) goat antimouse (Becton Dickinson) or goat antirat (Becton Dickinson) at the recommended concentrations. Negative controls were labeled with the second antibody alone. Gating for FACS analysis was performed as described previously.'' For immunoperoxidase, the enzyme was revealed through a S-minute incubation with Ortho-phenylenediamine (ONPG; I mg/mL; Sigma) at 37°C. The reaction was stopped with sulfuric acid, and the optical density was read at 570 nm.
RESULTS
SCL is expressed in primary erythroid progenitors and erythroid colony cells. The cellular heterogeneity of hematopoietic tissues complicates the analysis of lineageand stage-specific expression of genes, particularly in relatively undifferentiated precursor populations. A polyA RT-PCR technique has recently been described that allows the general amplification of polyadenylated transcripts from samples as small as a single cell with apparent preservation of relative abundance relationships.2' The protocol involves generation of first cDNA strands using an oligo (dT) primer, tailing of the strands with poly (dA), and subsequent amplification with a single oligo (dT)-containing The method has been used to generate amplified cDNA samples from single murine hematopoietic precursor cells taken from colony starts containing about eight cells each. The biologic potential of each processed cell was determined by analysis of the fates of its sister cells grown to maturity in culture in the presence of an optimal combination of growth factors for multilineage differentiation. The characteristics of the sample set and their validation with 3' untranslated region (UTR) probes for a variety of stage-and lineage-specific transcripts are described in detail elsewhere.23 For example, transcripts for both lysozyme and myeloperoxidase were found in macrophage precursors and terminally differentiating macrophages shown in Fig 2, whereas myeloperoxidase but not lysozyme transcripts were also found in neutrophil precursors. Globin expression was confined to both colonyforming units-erythroid (CFU-E)/proerythroblasts and both normoblasts. Hybridization to probes for housekeeping genes (ribosomal protein L32, GAPDH, and the syp phosphatase) was strong and relatively uniform throughout the sample set. 23 We designed a 3' UTR SCL probe that covers 439 bp adjacent to the polyadenylation signal (Fig l) . The PCR product showed the expected restriction fragments with BamHI, Kpn I, and Sty I (Fig 1) and hybridized as expected to SCL transcripts on Northern blots from MEL cells as described in Materials and Methods. Two independent transfers of single-cell cDNA samples were analyzed and quantitated for SCL expression. As shown in Fig 2, SCL RNA expression was highest in bipotent erythroidmegakaryocyte progenitors (E/Meg, or burst-forming units [BFUI-EMeg) and was also detectable in unipotential erythroid precursors at early (E, or BFU-E) and more advanced points (El, proerythroblasts or CFU-E) in the lineage.
SCL levels were lower in terminally maturing red cells (E2, normoblasts) shown elsewhere to express high levels of P-globin transcript~.*~ The variation in hybridization intensity between cDNA samples from precursors having identical potential is consistently observed with a wide variety of probes, each showing its own distinct pattern of variation, but not with probes from housekeeping genes as discussed above. The variation is currently believed to reflect intermittence of transcription of nonconstitutive genes at individual loci that is observable only at the single-cell level. 23 In contrast with the strong hybridizations observed in erythroid precursors, SCL RNA was lower in macrophage and neutrophil progenitors and diminished further with terminal maturation in these lineages. The results suggest that expression of SCL RNA occurs early in the hierarchy before specific restriction to erythropoiesis, persisting in cells committed uniquely to erythropoiesis and shutting down in cells committing exclusively to granulocytic or monocytic differentiation.
SCL expression in a bipotent cell line, TF-I. We next investigated whether this pattern of SCL expression in primary hematopoietic cells was reproduced during erythroid differentiation and monocytic differentiation of a bipotent cell line, TF-1. These cells express both an erythroid marker, glycophorin (YTH 89.1 ; Table l), and a monocyte/granulocyte marker (YTH39.1, data not shown). Northern blotting indicates that the cells constitutively express SCL, a-globin, and IL-lP RNA (Fig 3) . On induction of erythroid differentiation with &ALA, SCL mRNA levels remained relatively constant, but a-globin mRNA and the hemoglobin content per cell increased significantly (Figs 3, 6, and 7). Erythroid differentiation was also observed when cells were exposed to Epo instead of GM-CSF (Figs 3 and 7) , with a twofold increase in SCL transcripts comparable with that described for primary splenic erythroblasts of mice infected with the anemia-inducing strain of Friend virus.38 In contrast, TPA induction induced a fourfold decrease in SCL mRNA levels in the TF-l cells and a concomitant fivefold increase in IL-10 mRNA, a gene expressed in macrophages (Fig 3, left   panel) . The downregulation of SCL by TPA was sustained and was observed at 48 to 72 hours postinduction (data not shown). Hence, results observed with a human cell line, TF-1, resemble the pattern of SCL expression in primary murine hematopoietic cells; ie, SCL is expressed in the erythroid lineage and is downregulated with monocytic differentiation. TF-1 cells were accordingly chosen for further investigation of the functional significance of the divergent SCL expression pattern in the two lineages.
Ectopic SCL expression in TF-1 cells. To address directly the potential role of SCL in erythropoiesis and mono- cytopoiesis, we stably introduced the human SCL cDNA driven by the metallothionein promoter into TF-I cells. As a control, the vector without insert containing the neo selectable marker was also introduced into TF-I cells using Erythroid differentiation in the presence of GM-CSF. We have previously reported that TF-I cells undergo apoptosis after growth factor withdrawaL3' All differentiation experiments were, therefore, performed in the presence of trophic factors, GM-CSF,"' Steel factor (SF),." or E~o .~' Spontaneous and S-ALA-induced hemoglobinization was determined through benzidine staining. Glycophorin expression was quantitated through immunofluorescence analysis with the FACScan. As TF-I and all clones were established and maintained in the presence of GM-CSF, erythroid differentiation was first assessed under these conditions. Parental TF-l cells are more than 80% glycophorin-positive (Fig 5  and Table 1 ). In three of four SCL transfectants, glycophorin levels were higher, and the fluorescence profile of positive cells were skewed to the right as compared with that of the neo clones or of parental TF-I cells.
Because hemoglobinization is the ultimate criterion for erythroid differentiation, we addressed the possibility that SCL may also increase erythroid differentiation through benzidine staining. Spontaneous erythroid differentiation was highest in clone S30 and lowest in clone S27, which also correlated with . . .
c-"
Y the highest and lowest levels of SCL transgene expression, respectively. In response to &ALA, there were 15% to 20% benzidine-positive cells in all SCL transfectants, whereas the range was 4% to 8% for the neo clones and TF-I cells ( Fig  6) . Hence, ectopic SCL expression increased both spontaneous and 6-ALA-induced erythroid differentiation. We next investigated erythroid differentiation in the presence of varying concentrations of GM-CSF (data not shown). The range of GM-CSF concentrations was chosen such that even the lowest ( I ng/mL) would be optimal for TF-I cell survival." At low GM-CSF concentrations, there were 12% to 28% benzidine-positive cells in all clones in response to &ALA. At high GM-CSF concentrations, this percentage decreased to 3% in the neo clone but remained above the 12% level in S27 and S30. Thus, ectopic SCL expression favored the emergence of cells committed to erythroid differentiation under conditions that otherwise favored granulomonocytopoie~i~.'~~'~~~"
Erythroid differentiation in the presence of SF and Epo. In the presence of SF (Fig 7, right panel) , there was high spontaneous erythroid differentiation in three of four SCL transfectants (S9, S27, and S30), reaching as high as 20% benzidine-positive cells. On induction with S-ALA, one third to one half of the cells were benzidine-positive in all SCL transfectants, whereas cell differentiation remained at or below the 30% level for control cells. The difference between SCL transfectants and control cells was, however, not as high as that observed in GM-CSF-containing cultures.
Epo induces erythroid differentiation and increases SCL phosphorylation and DNA-binding activity in murine ery- throid cells.'* Interestingly, we found erythroid differentiation to be highest in the presence of Epo in all clones and unaffected by &ALA addition or by SCL overexpression (Fig 7, left panel) . Hence, the level of hemoglobinization measured on day 5 was 40% to 60% for all clones, whether or not &ALA was present as an inducer. These results are in contrast with those observed in GM-CSF-or SF-supported cultures, where erythroid differentiation was higher in SCL transfectants and was further increased by &ALA. Together. our experiments suggest that elevating SCL levels through ectopic expression or through induction with Epo results in increased erythroid differentiation. Clonogenic cell growth in the presence of GM-CSF. To address the question of whether ectopic SCL expression may affect cell proliferation, we analyzed the plating efficiency of all four SCL transfectants and all three neo clones taken in their exponential growth phase (Fig 8) . S27 and S31 cells grew, as did the neo clones GIO, G 13, and G14, whereas clonogenicity was significantly reduced in S9 and S30 transfectants that exhibit higher SCL transgene levels. Similarly, analysis of cumulative growth curves also suggests that cell growth was lower in SCL transfectants as compared with neo clones (data not shown). More recently, a dominant negative SCL was shown to affect apoptosis in Jurkat cells.'" To address the question of whether decreased growth in exponentially proliferating cells may be attributed to increased cell death, apoptosis was monitored in these cells by gel electrophoresis as described previously.3i.'2 There was no significant difference in apoptosis in SCL transfectants and in control cells (data not shown). Together, our observa- Table 1. tions suggest an inverse relationship between cell growth and cell differentiation.
Monocytic diferentintion induced by TPA. Because SCL is downregulated in primary monocytic cells and in TF-I cells induced to differentiate along the monocytic pathway with TPA, we investigated the functional implication of constitutive SCL expression in this process. Monocytic differentiation was assessed by IL-10 expression (Fig 3) , the generation of adherent cells, and the expression of a surface marker specific for macrophages, FcyRII (CDw32) (Fig 9) .
In all clones grown in the presence of GM-CSF, there were no adherent cells (data not shown). Exposure to TPA resulted in a significant increase in IL-Io expression (Fig 3) and induced the generation of adherent cells in half of the population in parental TF-I cells and in two neo clones, G10 and G13. To quantify the total number of adherent cells per culture, we determined their immunoreactivity with an anti-CD45 antibody through a whole-cell immunoperoxidase reaction (Fig 9A) . Because nonadherent cells were removed through extensive washing, the results represent a direct measurement of adherent cells induced by TPA. In contrast with the parental TF-I cells and neo clones, constitutive SCL expression interfered with the generation of adherent cells, and the extent of inhibition was better correlated to the level of SCL transgene expression than that observed with erythroid differentiation. Thus, the inhibition of monocytic differentiation was most dramatic in clone S30, which expressed the highest SCL level, and was minimal in clone S27, which was also the lowest SCL-expressing clone. This inverse correlation between SCL transgene expression and monocytic differentiation was not surprising, because ectopic SCL expression circumvents the downregulation of the endogenous gene by TPA. In erythroid differentiation, however, endogenous SCL mRNA remains elevated, and ectopic SCL expression results in increased SCL levels, the net result of which may not be a direct dosage effect. Interestingly, the expression of the monocytic marker FcyRIl was even more inhibited by constitutive SCL expression than the generation of adherent cells per se (Fig 9, compare A and  B) . Although TPA could still induce the generation of some adherent cells in clones S30 and S31, these cells did not express FcyRII. Collectively, our results indicate that constitutive SCL expression inhibits the induction of monocytic differentiation in response to TPA.
DISCUSSION
In the present study, we provide evidence for a dual role of SCL in hematopoiesis, that of a positive regulator of erythroid differentiation and of a negative regulator of monocytic differentiation.
Our first approach in addressing the function of SCL in hematopoiesis was to identify and quantitate SCL levels within distinct hematopoietic lineages and cells at different stages of differentiation. The intrinsic heterogeneity of hematopoietic tissues has not thus far allowed a definitive identification of SCL expression within defined functional hematopoietic progenitors. We have determined SCL expression through the screening of cDNA samples generated by RT-PCR from single cells. In this approach, one sister cell of a developing clone was used for RNA extraction, while the other members of the clone were allowed to grow to maturity in vitro, thus identifying the developmental potential of the processed cell." A feature frequently encountered at the single-cell level but less so in a pooled population is the sampleto-sample variation within a set of progenitors having the same developmental potential. This heterogeneity is not observed for genes that are constitutively expressed such as GAPDH, L32, and syp, suggesting that it is not generated artefactually by the process of reverse transcription and PCR. Rather, it is believed to reflect the stability of the transcript and the intermittence of transcription at a locus in a single cell.*' Thus, correlation of gene expression with specific developmental stages becomes apparent when analyzed in the context of sample sets rather than in the context of individual samples. SCL levels were highest within the bipotent BFUElMeg and the BFU-E cell types and were maintained during subsequent maturation through CFU-E and proerythroblasts. In contrast, SCL RNA levels decreased with commitment into granulocytic or monocytic differentiation and dimin- ished further with terminal maturation. This pattern of expression was reproduced in the bipotent cell line TF-I induced to differentiate along different pathways (the present study) and in other human and murine cell line^.'".^' To address directly the potential function of SCL in cell differentiation, we expressed it constitutively in a bipotent erythroidhonocytic cell line. Sustained SCL favored erythroid differentiation while inhibiting monocytic differentiation. These observations would be compatible with a role for SCL in driving erythroid commitment while inhibiting commitment into monocytic differentiation.
SCL overexpression in TF-I cells results in increased erythroid differentiation in different culture conditions, as assessed by the levels of glycophorin expression and of hemoglobinization of individual cells. These data are concordant with our previous observations that ectopic SCL expression overcomes the block in erythroid differentiation in MEL cells.14 It is believed that MEL cell lines arise from cells that are already committed to erythroid differentiation. Thus, using MEL cells, it was not possible to address the question of a more general role for SCL in hematopoiesis. In contrast, TF-I cells are bipotent and are growth factor-dependent, allowing for an assessment of the consequence of SCL overexpression on development into two lineages as well as on factor dependence. Our experiments showed a marked enhancement of erythroid differentiation by enforced SCL expression. even in the presence of high GM-CSF concentrations ordinarily more permissive for granulocyte-macrophage differentiation.'".' '' In both primary hematopoietic cells and in the model cell line TF-I , SCL expression is downregulated with monocytic differentiation. Our experiments indicate that constitutive SCL expression prevents the generation of adherent cells in culture induced by TPA. Although TPA has previously been shown to downregulate erythroid transcription factors:'.'" our data suggest that the downregulation of SCL may be an essential step in TPA-induced monocytic differentiation. It is possible that SCL overexpression disrupts the equilibrium of transcription complexes and prevents the expression of monocytic genes, reminiscent of the inhibition of myeloid differentiation by id."^'" The striking parallel between SCL expression in primary hematopoietic cells and during the process of erythroid or monocytic differentiation of our model cell line strongly suggests that these observations are relevant to hematopoiesis in vivo.
Analysis of plating efficiencies and of cumulative growth curves in the presence of GM-CSF indicated a significant retardation of cell proliferation in SCL transfectants. In exponentially growing cells, we did not observe variations in apoptosis in SCL transfectants and control cells, suggesting that the retardation of cell growth may be related to increased erythroid differentiation. at least in the TF-I model. The delay in cell growth in the presence of GM-CSF does not. however, preclude a role for SCL in self-renewal. In fact. we were able to easily obtain clones expressing the SCL cDNA in the sense orientation (data herein) but not in the antisense orientation (T.H. and I.R.K., unpublished observations. June 1993). It is possible that expression of an antisense SCL is incompatible with self-renewal or with the long-term propagation of the cells. Thus. in the human cell line KS62, which is believed to represent an early precursor:' an antisense SCL was shown to reduce secondary plating efficiency,'5 whereas MEL cells expressing the antisense SCL or a dominant negative mutant were not affected in their doubling time.'' Furthermore. Jurkat leukemic T cells that have lost SCL function have been shown to undergo premature apoptosis under conditions of nutriment deprivation." Finally, in mice lacking SCL, there was a general deficiency in cells of the erythroid, megakaryocyte, and granulocyte-macrophage lineages."' Collectively. the data suggest that SCL may fulfill an essential function unrelated to cell differentiation in primitive hematopoietic precursors. but not in more advanced CFU-E-type erythroid precursors. Recently, SCL has been shown to be coexpressed with RBTN2 in erythroid cells'" and to associate in vivo with this molecule. Furthermore. the expression of both SCL (data herein and Mouthon et al'") and RBTN2'" decreases as erythroid cells progress towards terminal differentiation, suggesting the possibility of altered equilibrium within transcription complexes, which could result in a shift or restriction in the spectrum of target genes within the erythroid lineage. The role of SCL may, therefore, be more complex than anticipated. In primitive precursors, SCL may favor long-term proliferation'5,'" and erythroid differentiation (the present study), whereas in more advanced precursors (MEL cells). the role of SCL may be restricted to favoring erythroid differentiation." Furthermore. the downregulation of SCL may be required for terminal differentiation into the monocytic and. possibly, the granulocytic lineages. Thus. sustained SCL expression in erythroid cells may serve to prevent lineage infidelity and the aberrant expression of monocytic markers in normal erythroid differentiation.
In T-cell ALL. SCL expression driven by nonrandom chromosomal translocations does not promote the expression of an erythroid phenotype. Rather, SCL expression appears to protect the cells from premature apoptosis. The transcriptional activity of members of the bHLH family has been For personal use only. on October 23, 2017 . by guest www.bloodjournal.org From shown to depend on the identity of their dimerization partn e r~.~' .~* It is possible that SCL or RBTN2 may associate with other proteins in cells committed to the T lineage," resulting in a drastic change in transcriptional activity and leukemogenesis.
